Tuesday, November 23, 2010

New anti-HIV drug may work as a "pseudo-vaccine"

A study of an anti-HIV drug called Truvada (a combination of tenofovir and emtricitabine) may be effective in preventing HIV infection if in HIV-negative men if the MSM take it as prevention. Taken daily, it may reduce risk of infection by 73%. It would cost over $8000 a year right now. This does not mean that other forms of prophylaxis and condoms can safely be stopped.

The findings were reported by David Paltiel at Yale University.

The news story by Steve Sternberg appeared in USA Today on Nov 23, at this link

ABC’s Richard Besser says that there are about 50000 new infections in the US every year.

Here is a link on Truvada side effects (link). Nausea is reported in some users, as is mild skin discoloration.

No comments: